Literature DB >> 24264182

Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction.

Helena Forsslund1, Mikael Mikko2, Reza Karimi2, Johan Grunewald2, Åsa M Wheelock2, Jan Wahlström2, C Magnus Sköld2.   

Abstract

BACKGROUND: COPD is characterized by chronic inflammation. CD8+ T cells and CD4+ T cells have both been implicated in the inflammatory response. We investigated whether the lymphocyte and T-cell subpopulations in BAL differ between patients with COPD who are current smokers and those who are ex-smokers.
METHODS: Forty never smokers, 40 smokers with normal lung function, and 38 patients with COPD, GOLD (Global Initiative for Chronic Obstructive Pulmonary Disease) stage I-II (27 smokers and 11 ex-smokers) underwent BAL. Using flow cytometry, cells were analyzed from BAL and blood for T-cell subsets, B cells, natural killer cells, and natural killer T (NKT)-like cells. The differentiation status of CD4+ T cells was also determined.
RESULTS: Smokers with or without COPD had higher percentages of CD8+ T cells and NKT-like cells in BAL than did never smokers and ex-smokers with COPD. Most of the NKT-like cells were CD8+. In contrast, the percentages of CD4+ T cells were lower in the smoking than in the nonsmoking groups. In blood, the frequency of CD4+ T cells was increased in the two smoking groups. Current smokers also had increased numbers of activated (CD69+) naive and effector CD4+ T cells in BAL compared with nonsmokers, particularly in patients with COPD. In male smokers with COPD, the percentage of CD8+ T cells in BAL positively correlated with the number of cigarettes per day.
CONCLUSIONS: Current smoking status has a greater impact than airway obstruction on the distribution of T-cell subsets in BAL of patients with mild to moderate COPD. This fact must be considered when the role of T cells in COPD is evaluated. Our results stress the importance of subgrouping patients with COPD in terms of smoking.

Entities:  

Mesh:

Year:  2014        PMID: 24264182     DOI: 10.1378/chest.13-0873

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  34 in total

1.  An LC-MS/MS workflow to characterize 16 regio- and stereoisomeric trihydroxyoctadecenoic acids.

Authors:  David Fuchs; Mats Hamberg; C Magnus Sköld; Åsa M Wheelock; Craig E Wheelock
Journal:  J Lipid Res       Date:  2018-07-31       Impact factor: 5.922

2.  Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers.

Authors:  Gregory H Taylor; Adrienne A Williams; Alfredo Garzino-Demo
Journal:  Pathog Dis       Date:  2015-12-09       Impact factor: 3.166

3.  Interleukin-26 Production in Human Primary Bronchial Epithelial Cells in Response to Viral Stimulation: Modulation by Th17 cytokines.

Authors:  Karlhans Fru Che; Riitta Kaarteenaho; Elisa Lappi-Blanco; Bettina Levänen; Jitong Sun; Åsa Wheelock; Lena Palmberg; C Magnus Sköld; Anders Lindén
Journal:  Mol Med       Date:  2017-08-29       Impact factor: 6.354

4.  Lung density on high resolution computer tomography (HRCT) reflects degree of inflammation in smokers.

Authors:  Reza Karimi; Göran Tornling; Helena Forsslund; Mikael Mikko; Åsa M Wheelock; Sven Nyrén; Carl Magnus Sköld
Journal:  Respir Res       Date:  2014-02-24

5.  Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease.

Authors:  Christine M Freeman; Valerie R Stolberg; Sean Crudgington; Fernando J Martinez; MeiLan K Han; Stephen W Chensue; Douglas A Arenberg; Catherine A Meldrum; Lisa McCloskey; Jeffrey L Curtis
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

6.  Diagnostic Performance of Bronchoalveolar Lavage Fluid CD4/CD8 Ratio for Sarcoidosis: A Meta-analysis.

Authors:  Yongchun Shen; Caishuang Pang; Yanqiu Wu; Diandian Li; Chun Wan; Zenglin Liao; Ting Yang; Lei Chen; Fuqiang Wen
Journal:  EBioMedicine       Date:  2016-04-21       Impact factor: 8.143

Review 7.  Metabolic reprogramming: A driver of cigarette smoke-induced inflammatory lung diseases.

Authors:  Linhui Li; David C Yang; Ching-Hsien Chen
Journal:  Free Radic Biol Med       Date:  2020-12-30       Impact factor: 7.376

8.  Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis.

Authors:  Mingming Deng; Yan Yin; Qin Zhang; Xiaoming Zhou; Gang Hou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

9.  Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood.

Authors:  Christine M Freeman; Carlos H Martinez; Jill C Todt; Fernando J Martinez; MeiLan K Han; Deborah L Thompson; Lisa McCloskey; Jeffrey L Curtis
Journal:  Respir Res       Date:  2015-08-05

10.  Peripheral Tc17 and Tc17/Interferon-γ Cells are Increased and Associated with Lung Function in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Wei-Han Xu; Xiao-Ling Hu; Xiao-Fang Liu; Peng Bai; Yong-Chang Sun
Journal:  Chin Med J (Engl)       Date:  2016-04-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.